The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients: response to Poulsen et al
- PMID: 15220287
- DOI: 10.2337/diacare.27.7.1846-a
The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients: response to Poulsen et al
Comment on
-
The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients.Diabetes Care. 2003 Dec;26(12):3273-9. doi: 10.2337/diacare.26.12.3273. Diabetes Care. 2003. PMID: 14633813 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
